Segall Bryant & Hamill’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,347
| Closed | -$311K | – | 524 |
|
|
2023
Q2 | $311K | Buy |
4,347
+235
| +6% | +$16.8K | ﹤0.01% | 637 |
|
|
2023
Q1 | $285K | Hold |
4,112
| – | – | ﹤0.01% | 649 |
|
|
2022
Q4 | $278K | Hold |
4,112
| – | – | ﹤0.01% | 657 |
|
|
2022
Q3 | $226K | Buy |
4,112
+89
| +2% | +$4.89K | ﹤0.01% | 685 |
|
|
2022
Q2 | $265K | Sell |
4,023
-300
| -7% | -$19.8K | ﹤0.01% | 678 |
|
|
2022
Q1 | $287K | Buy |
+4,323
| New | +$287K | ﹤0.01% | 684 |
|
|
2021
Q4 | – | Sell |
-3,907
| Closed | -$234K | – | 603 |
|
|
2021
Q3 | $234K | Buy |
3,907
+34
| +0.9% | +$2.04K | ﹤0.01% | 742 |
|
|
2021
Q2 | $232K | Sell |
3,873
-23,180
| -86% | -$1.39M | ﹤0.01% | 723 |
|
|
2021
Q1 | $1.35M | Buy |
+27,053
| New | +$1.35M | 0.01% | 517 |
|